Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Nutex Health (NUTX) Return on Equity (2016 - 2025)

Nutex Health's Return on Equity history spans 13 years, with the latest figure at 0.52% for Q2 2025.

  • For Q2 2025, Return on Equity rose 88.0% year-over-year to 0.52%; the TTM value through Jun 2025 reached 0.52%, up 88.0%, while the annual FY2024 figure was 0.71%, 114.0% up from the prior year.
  • Return on Equity for Q2 2025 was 0.52% at Nutex Health, down from 0.63% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.71% in Q4 2024 and bottomed at 4.08% in Q2 2023.
  • The 5-year median for Return on Equity is 0.25% (2023), against an average of 0.75%.
  • The largest annual shift saw Return on Equity plummeted -417bps in 2023 before it skyrocketed 372bps in 2024.
  • A 5-year view of Return on Equity shows it stood at 0.0% in 2021, then crashed by -806195bps to 3.42% in 2022, then soared by 86bps to 0.47% in 2023, then skyrocketed by 250bps to 0.71% in 2024, then fell by -27bps to 0.52% in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Return on Equity are 0.52% (Q2 2025), 0.63% (Q1 2025), and 0.71% (Q4 2024).